Aurobindo Pharma shares in focus after Q3 profit drops 10% YoY. Should you buy or sell?
- Posted on February 7, 2025
- By Business News Today
- 5 Views
Aurobindo Pharma shares in focus after Q3 profit drops 10% YoY. Should you buy or sell?
Aurobindo Pharmas Q3 net profit declined 10% YoY to Rs 846 crore, despite record revenue of Rs 7,979 crore. US sales remained weak, but Europe and antiretrovirals grew. Analysts gave mixed ratings, citing profitability improvements and US market trends.
